Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.
View/ Open
Date
2018-02-15Author
Annibaldi, A
Wicky John, S
Vanden Berghe, T
Swatek, KN
Ruan, J
Liccardi, G
Bianchi, K
Elliott, PR
Choi, SM
Van Coillie, S
Bertin, J
Wu, H
Komander, D
Vandenabeele, P
Silke, J
Meier, P
Type
Journal Article
Metadata
Show full item recordAbstract
Tumor necrosis factor (TNF) can drive inflammation, cell survival, and death. While ubiquitylation-, phosphorylation-, and nuclear factor κB (NF-κB)-dependent checkpoints suppress the cytotoxic potential of TNF, it remains unclear whether ubiquitylation can directly repress TNF-induced death. Here, we show that ubiquitylation regulates RIPK1's cytotoxic potential not only via activation of downstream kinases and NF-kB transcriptional responses, but also by directly repressing RIPK1 kinase activity via ubiquitin-dependent inactivation. We find that the ubiquitin-associated (UBA) domain of cellular inhibitor of apoptosis (cIAP)1 is required for optimal ubiquitin-lysine occupancy and K48 ubiquitylation of RIPK1. Independently of IKK and MK2, cIAP1-mediated and UBA-assisted ubiquitylation suppresses RIPK1 kinase auto-activation and, in addition, marks it for proteasomal degradation. In the absence of a functional UBA domain of cIAP1, more active RIPK1 kinase accumulates in response to TNF, causing RIPK1 kinase-mediated cell death and systemic inflammatory response syndrome. These results reveal a direct role for cIAP-mediated ubiquitylation in controlling RIPK1 kinase activity and preventing TNF-mediated cytotoxicity.
Collections
Subject
Animals
Mice, Inbred C57BL
Mice, Knockout
Humans
Mice
Protein-Serine-Threonine Kinases
MAP Kinase Kinase Kinases
Tumor Necrosis Factor-alpha
Intracellular Signaling Peptides and Proteins
NF-kappa B
Ubiquitin
Signal Transduction
Apoptosis
Inhibitor of Apoptosis Proteins
I-kappa B Kinase
Receptor-Interacting Protein Serine-Threonine Kinases
Ubiquitination
HEK293 Cells
Baculoviral IAP Repeat-Containing 3 Protein
Research team
Cell Death and Immunity
Language
eng
Date accepted
2018-01-19
License start date
2018-02
Citation
Molecular cell, 2018, 69 (4), pp. 566 - 580.e5
Publisher
CELL PRESS
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/4.0
Related items
Showing items related by title, author, creator and subject.
-
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours.
Jamieson, D; Griffin, MJ; Sludden, J; Drew, Y; Cresti, N; et al. (ELSEVIER SCI LTD, 2016-11-01)PURPOSE: We performed a multi-centre phase I study to assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of the orally available small molecule mitogen-activated protein kinase kinase (MEK) 1/2 inhibitor, ... -
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
Jaco, I; Annibaldi, A; Lalaoui, N; Wilson, R; Tenev, T; et al. (CELL PRESS, 2017-06-01)TNF is an inflammatory cytokine that upon binding to its receptor, TNFR1, can drive cytokine production, cell survival, or cell death. TNFR1 stimulation causes activation of NF-κB, p38α, and its downstream effector kinase ... -
MEKK3 coordinates with FBW7 to regulate WDR62 stability and neurogenesis.
Xu, D; Yao, M; Wang, Y; Yuan, L; Hoeck, JD; et al. (PUBLIC LIBRARY SCIENCE, 2018-12-01)Mutations of WD repeat domain 62 (WDR62) lead to autosomal recessive primary microcephaly (MCPH), and down-regulation of WDR62 expression causes the loss of neural progenitor cells (NPCs). However, how WDR62 is regulated ...